Davide Rossi

28.9k total citations · 3 hit papers
337 papers, 9.3k citations indexed

About

Davide Rossi is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Davide Rossi has authored 337 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 196 papers in Genetics, 166 papers in Pathology and Forensic Medicine and 95 papers in Oncology. Recurrent topics in Davide Rossi's work include Chronic Lymphocytic Leukemia Research (190 papers), Lymphoma Diagnosis and Treatment (159 papers) and Immunodeficiency and Autoimmune Disorders (39 papers). Davide Rossi is often cited by papers focused on Chronic Lymphocytic Leukemia Research (190 papers), Lymphoma Diagnosis and Treatment (159 papers) and Immunodeficiency and Autoimmune Disorders (39 papers). Davide Rossi collaborates with scholars based in Italy, Switzerland and United States. Davide Rossi's co-authors include Gianluca Gaïdano, Valeria Spina, Daniela Capello, Riccardo Dalla‐Favera, Laura Pasqualucci, Raúl Rabadán, Valter Gattei, Silvia Deaglio, Silvia Rasi and Amy Chadburn and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Davide Rossi

321 papers receiving 9.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Analysis of the coding genome of diffuse large B-cell lymphoma

2011 673 citations Laura Pasqualucci, Davide Rossi et al. profile →
Inactivating mutations of acetyltransferase genes in B-cell lymphoma

2011 644 citations Laura Pasqualucci, Davide Rossi et al. profile →
Genetics of Follicular Lymphoma Transformation

2014 376 citations Laura Pasqualucci, Hossein Khiabanian et al. profile →

Peers

Countries citing papers authored by Davide Rossi

Since Specialization

Citations

This map shows the geographic impact of Davide Rossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davide Rossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davide Rossi more than expected).

Fields of papers citing papers by Davide Rossi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Davide Rossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davide Rossi. The network helps show where Davide Rossi may publish in the future.

Co-authorship network of co-authors of Davide Rossi

This figure shows the co-authorship network connecting the top 25 collaborators of Davide Rossi. A scholar is included among the top collaborators of Davide Rossi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Davide Rossi. Davide Rossi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Resistance to targeted therapies in chronic lymphocytic leukemia: Current status and perspectives for clinical and diagnostic practice 2025 ·Leukemia ·Piers Blombery, Thomas Chatzikonstantinou, (unknown), Richard Rosenquist, Gianluca Gaïdano, Šárka Pospı́šilová, Andrew W. Roberts, Richard W. Birkinshaw, Davide Rossi, Lydia Scarfò, John F. Seymour, Stephan Stilgenbauer, Adrian Wiestner, Jennifer A. Woyach, (unknown), Paolo Ghia, Κώστας Σταματόπουλος	0
2	MRD‐NEGATIVITY AFTER FRONTLINE DLBCL THERAPY: POOLED ANALYSIS OF 6 CLINICAL TRIALS 2023 ·Hematological Oncology ·Mark Roschewski, David M. Kurtz, Jason R. Westin, Ryan C. Lynch, Stefan Alig, Calum MacAulay, Christian Kuffer, (unknown), André Schultz, Sandra Close, (unknown), Davide Rossi, Stephen Opat, Rodney J. Hicks, Mark Hertzberg, Maximilian Diehn, Wyndham H. Wilson, Ash A. Alizadeh	5
3	ETS1 phosphorylation at threonine 38 is associated with the cell of origin of diffuse large B cell lymphoma and sustains the growth of tumour cells 2023 ·British Journal of Haematology ·Elaine Y. Chung, Giulio Sartori, Maurilio Ponzoni, Luciano Cascione, (unknown), Zijun Y. Xu‐Monette, Xiaosheng Fang, Mingzhi Zhang, Carlo Visco, Alexandar Tzankov, Andrea Rinaldi, Jacopo Sgrignani, Emanuele Zucca, Davide Rossi, Andrea Cavalli, Giorgio Inghirami, David W. Scott, Ken H. Young, Francesco Bertoni	2
4	Oropharyngeal squamous cell carcinoma: Prognostic factors for development of distant metastases and oncological outcomes 2023 ·Head & Neck ·Francesco Mattioli, (unknown), (unknown), (unknown), Davide Rossi, (unknown), Roberto Tonelli, Matteo Fermi, Giuseppe Pugliese, Federica Bertolini, Elisa D’Angelo, Roberta Depenni, Massimo Dominici, Frank Lohr, Daniele Marchioni	6
5	Prevalence of amyloid in ligamentum flavum of patients with lumbar spinal stenosis 2023 ·Amyloid ·Francesco Marchi, (unknown), Daniela Distefano, Lodovico Terzi di Bergamo, Luca Fumagalli, (unknown), (unknown), (unknown), Giorgia Melli, Georg Stüssi, Davide Rossi, Claudio Gobbi, Paolo Ripellino, Emanuele Pravatà, Dominique Kuhlen, Christoph Röcken, Pietro Scarone, B. Gerber, Adalgisa Condoluci	5
6	CIRCULATING TUMOR DNA (LIQUID BIOPSY) 2023 ·Hematological Oncology ·Davide Rossi	1
7	Baseline circulating tumour DNA and interim PET predict response in relapsed/refractory classical Hodgkin lymphoma 2023 ·British Journal of Haematology ·(unknown), Martina Di Trani, Francesco Corrado, Martina Sollini, (unknown), (unknown), Lodovico Terzi di Bergamo, Alessio Bruscaggin, Maria Cristina Pirosa, Stéfania Bramanti, Arturo Chiti, Davide Rossi, Carmelo Carlo‐Stella	7
8	Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma 2021 ·Proceedings of the National Academy of Sciences ·Marco Fangazio, Erik Ladewig, (unknown), Laura Garcia‐Ibanez, Rahul Kumar, Julie Teruya‐Feldstein, Davide Rossi, Ioan Filip, Qiang Pan‐Hammarström, Giorgio Inghirami, Renzo Boldorini, German Ott, Annette M. Staiger, Bjoern Chapuy, Gianluca Gaïdano, Govind Bhagat, Katia Basso, Raúl Rabadán, Laura Pasqualucci, Riccardo Dalla‐Favera	53
9	Nanosponges as protein delivery systems: Insulin, a case study 2020 ·International Journal of Pharmaceutics ·Silvia Lucia Appleton, Maria Tannous, Monica Argenziano, Elisabetta Muntoni, Arianna Carolina Rosa, Davide Rossi, Fabrizio Caldera, Anna Scomparin, Francesco Trotta, Roberta Cavalli	43
10	Diffuse large B-cell lymphoma genotyping on the liquid biopsy 2017 ·Blood ·Davide Rossi, Fary Diop, Elisa Spaccarotella, Sara Monti, Manuela Zanni, Silvia Rasi, Clara Deambrogi, Valeria Spina, Alessio Bruscaggin, Chiara Favini, Roberto Serra, Antonio Ramponi, Renzo Boldorini, Robin Foà, Gianluca Gaïdano	181
11	Splenic marginal zone lymphoma: from genetics to management 2016 ·Blood ·Luca Arcaini, Davide Rossi, Marco Paulli	100
12	Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia 2014 ·Blood ·Davide Rossi, Hossein Khiabanian, Valeria Spina, Carmela Ciardullo, Alessio Bruscaggin, Rosella Famà, Silvia Rasi, Sara Monti, Clara Deambrogi, Lorenzo De Paoli, Jiguang Wang, Valter Gattei, Anna Guarini, Robin Foà, Raúl Rabadán, Gianluca Gaïdano	228
13	Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study 2013 ·Blood ·Alessandra Larocca, Vittorio Montefusco, Sara Bringhen, Davide Rossi, Claudia Crippa, Roberto Mina, Mónica Galli, Magda Marcatti, Giacinto La Verde, Nicola Giuliani, Valeria Magarotto, Tommasina Guglielmelli, Delia Rota‐Scalabrini, Paola Omedè, Alberto Santagostino, Ileana Baldi, Angelo Michele Carella, Mario Boccadoro, Paolo Corradini, Antonio Palumbo	66
14	CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanism 2013 ·Blood ·Antonella Zucchetto, (unknown), Dania Benedetti, Erika Tissino, Francesca Maria Rossi, (unknown), Federico Pozzo, Riccardo Bomben, Michele Dal Bo, Giovanni D’Arena, Francesco Zaja, Gabriele Pozzato, Francesco Di Raimondo, Tanja Nicole Hartmann, Davide Rossi, Gianluca Gaïdano, Giovanni Del Poeta, Valter Gattei	38
15	Nicotinamide Blocks Proliferation and Induces Apoptosis of Chronic Lymphocytic Leukemia Cells through Activation of the p53/miR-34a/SIRT1 Tumor Suppressor Network 2011 ·Cancer Research ·Valentina Audrito, Tiziana Vaisitti, Davide Rossi, Daniela Gottardi, Giovanni D’Arena, Luca Laurenti, Gianluca Gaïdano, Fabio Malavasi, Silvia Deaglio	138
16	E2A is a transcriptional regulator of CD38 expression in chronic lymphocytic leukemia 2011 ·Leukemia ·Ifigènia Saborit-Villarroya, Tiziana Vaisitti, Davide Rossi, Giovanni D’Arena, Gianluca Gaïdano, Fabio Malavasi, Silvia Deaglio	29
17	The NF-κB negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas 2009 ·Blood ·Urban Novak, Andrea Rinaldi, Ivo Kwee, Subhadra V. Nandula, Paola M. V. Rancoita, Mara Compagno, Michaela Cerri, Davide Rossi, Vundavalli V. Murty, Emanuele Zucca, Gianluca Gaïdano, Riccardo Dalla‐Favera, Laura Pasqualucci, Govind Bhagat, Francesco Bertoni	184
18	CD38/CD31, the CCL3 and CCL4 Chemokines, and CD49d/Vascular Cell Adhesion Molecule-1 Are Interchained by Sequential Events Sustaining Chronic Lymphocytic Leukemia Cell Survival 2009 ·Cancer Research ·Antonella Zucchetto, Dania Benedetti, Claudio Tripodo, Riccardo Bomben, Michele Dal Bo, Daniela Marconi, Fleur Bossi, Debora Lorenzon, Massimo Degan, Francesca Maria Rossi, Davide Rossi, Pietro Bulian, Vito Franco, Giovanni Del Poeta, Silvia Deaglio, Gianluca Gaïdano, Francesco Tedesco, Fabio Malavasi, Valter Gattei	118
19	The Prognostic Value of TP53 Mutations in Chronic Lymphocytic Leukemia Is Independent of Del17p13: Implications for Overall Survival and Chemorefractoriness 2009 ·Clinical Cancer Research ·Davide Rossi, Michaela Cerri, Clara Deambrogi, Elisa Sozzi, Stefania Cresta, Silvia Rasi, Lorenzo De Paoli, Valeria Spina, Valter Gattei, Daniela Capello, Francesco Forconi, Francesco Lauria, Gianluca Gaïdano	206
20	Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B‐cell lymphomas 2009 ·Hematological Oncology ·Marta Scandurra, Davide Rossi, Clara Deambrogi, Paola M. V. Rancoita, Ekaterina Chigrinova, Michael Mian, Michaela Cerri, Silvia Rasi, Elisa Sozzi, Francesco Forconi, Maurilio Ponzoni, Santiago Montes‐Moreno, Miguel Á. Piris, Giorgio Inghirami, Emanuele Zucca, Valter Gattei, Andrea Rinaldi, Ivo Kwee, Gianluca Gaïdano, Francesco Bertoni	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact